柏堡龍(002776.SZ):截至3月底 已投產10條防護口罩生產線及6條防護服生產線
格隆匯4月10日丨柏堡龍(002776.SZ)公佈,公司為全國疫情防控重點保障企業之一,截至2020年3月31日已投資2371.2萬元建設防護口罩、防護服生產線。防護口罩、防護服生產線建設進展情況如下:
1、公司已取得揭陽市市場監督管理局頒發的“醫用防護口罩”《揭陽市防控急用器械備案信息表》(備案號:粵揭械應急備004號)、“一次性醫用防護服”《揭陽市防控急用器械備案信息表》(備案號:粵揭械應急備005號)及“醫用防護口罩、一次性醫用防護服”《揭陽市防控急用醫療器械生產備案憑證》(備案號:粵揭械生產應急備2020010號)。公司醫用口罩(非滅菌)已取得CE認證文件。公司民用和醫用口罩(N95口罩除外)、防護服(非外科)已按照美國食品藥品監督管理局(FDA)要求完成註冊(註冊號:10063604)。
2、截至2020年3月31日,公司已投產防護口罩生產線10條,日產能達100萬個;公司已投產防護服生產線6條,月產能達30萬套。
3、公司目前生產的防護口罩及防護服主要向國內市場銷售,部分向國外市場銷售(出口銷售佔比較小)。
值得注意的是,近日,公司總經理陳娜娜曾接受中央電視台欄目採訪時將“防護口罩日產能 100萬個、防護服月產能30萬套”口誤為“防護口罩日產量100萬個、防護服日產量30萬套”,陳娜娜對此深表歉意。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.